New avenues for the prevention of colorectal cancer: Targeting cyclo-oxygenase-2 activity

Rajnish A. Gupta, Raymond N. DuBois, Mina C. Wallace

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Carcinoma of the colon and/or rectum represents the second most common gastrointestinal malignancy worldwide. Despite this prevalence, current therapeutic regimens remain largely ineffectual, particularly when the disease is diagnosed at an advanced stage. Recent work in the field of colorectal cancer has established that a chronic intake of non steroidal anti-inflammatory drugs can reduce the risk of developing colorectal cancer. Although the precise mechanism(s) by which these drugs inhibit tumour growth is not completely understood, it is likely that at least a part of their anti-tumorigenic effects results from an inhibition of the cyclo-oxygenase-2 enzyme. This chapter will focus on this emerging research area and the promise it brings for identifying new strategies for the prevention of colorectal cancer.

Original languageEnglish (US)
Pages (from-to)945-956
Number of pages12
JournalBailliere's Best Practice and Research in Clinical Gastroenterology
Volume16
Issue number6
DOIs
StatePublished - Dec 2002
Externally publishedYes

Fingerprint

Prostaglandin-Endoperoxide Synthases
Colorectal Neoplasms
Rectum
Pharmaceutical Preparations
Neoplasms
Colon
Anti-Inflammatory Agents
Carcinoma
Enzymes
Growth
Research
Therapeutics

Keywords

  • Angiogenesis
  • Colon cancer
  • Cyclo-oxygenase
  • Prevention

ASJC Scopus subject areas

  • Gastroenterology

Cite this

New avenues for the prevention of colorectal cancer : Targeting cyclo-oxygenase-2 activity. / Gupta, Rajnish A.; DuBois, Raymond N.; Wallace, Mina C.

In: Bailliere's Best Practice and Research in Clinical Gastroenterology, Vol. 16, No. 6, 12.2002, p. 945-956.

Research output: Contribution to journalArticle

@article{8abf93c3e4f84d7894f83d975015fc32,
title = "New avenues for the prevention of colorectal cancer: Targeting cyclo-oxygenase-2 activity",
abstract = "Carcinoma of the colon and/or rectum represents the second most common gastrointestinal malignancy worldwide. Despite this prevalence, current therapeutic regimens remain largely ineffectual, particularly when the disease is diagnosed at an advanced stage. Recent work in the field of colorectal cancer has established that a chronic intake of non steroidal anti-inflammatory drugs can reduce the risk of developing colorectal cancer. Although the precise mechanism(s) by which these drugs inhibit tumour growth is not completely understood, it is likely that at least a part of their anti-tumorigenic effects results from an inhibition of the cyclo-oxygenase-2 enzyme. This chapter will focus on this emerging research area and the promise it brings for identifying new strategies for the prevention of colorectal cancer.",
keywords = "Angiogenesis, Colon cancer, Cyclo-oxygenase, Prevention",
author = "Gupta, {Rajnish A.} and DuBois, {Raymond N.} and Wallace, {Mina C.}",
year = "2002",
month = "12",
doi = "10.1053/bega.2002.0353",
language = "English (US)",
volume = "16",
pages = "945--956",
journal = "Bailliere's Best Practice and Research in Clinical Gastroenterology",
issn = "1521-6918",
publisher = "Bailliere Tindall Ltd",
number = "6",

}

TY - JOUR

T1 - New avenues for the prevention of colorectal cancer

T2 - Targeting cyclo-oxygenase-2 activity

AU - Gupta, Rajnish A.

AU - DuBois, Raymond N.

AU - Wallace, Mina C.

PY - 2002/12

Y1 - 2002/12

N2 - Carcinoma of the colon and/or rectum represents the second most common gastrointestinal malignancy worldwide. Despite this prevalence, current therapeutic regimens remain largely ineffectual, particularly when the disease is diagnosed at an advanced stage. Recent work in the field of colorectal cancer has established that a chronic intake of non steroidal anti-inflammatory drugs can reduce the risk of developing colorectal cancer. Although the precise mechanism(s) by which these drugs inhibit tumour growth is not completely understood, it is likely that at least a part of their anti-tumorigenic effects results from an inhibition of the cyclo-oxygenase-2 enzyme. This chapter will focus on this emerging research area and the promise it brings for identifying new strategies for the prevention of colorectal cancer.

AB - Carcinoma of the colon and/or rectum represents the second most common gastrointestinal malignancy worldwide. Despite this prevalence, current therapeutic regimens remain largely ineffectual, particularly when the disease is diagnosed at an advanced stage. Recent work in the field of colorectal cancer has established that a chronic intake of non steroidal anti-inflammatory drugs can reduce the risk of developing colorectal cancer. Although the precise mechanism(s) by which these drugs inhibit tumour growth is not completely understood, it is likely that at least a part of their anti-tumorigenic effects results from an inhibition of the cyclo-oxygenase-2 enzyme. This chapter will focus on this emerging research area and the promise it brings for identifying new strategies for the prevention of colorectal cancer.

KW - Angiogenesis

KW - Colon cancer

KW - Cyclo-oxygenase

KW - Prevention

UR - http://www.scopus.com/inward/record.url?scp=0036886807&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036886807&partnerID=8YFLogxK

U2 - 10.1053/bega.2002.0353

DO - 10.1053/bega.2002.0353

M3 - Article

C2 - 12473300

AN - SCOPUS:0036886807

VL - 16

SP - 945

EP - 956

JO - Bailliere's Best Practice and Research in Clinical Gastroenterology

JF - Bailliere's Best Practice and Research in Clinical Gastroenterology

SN - 1521-6918

IS - 6

ER -